Related Experiment Video
Updated: Nov 3, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Clinical Features and Diagnosis of Cardiac Sarcoidosis
Claudio Tana1, Cesare Mantini2, Iginio Donatiello3
1COVID-19 Medicine Unit and Geriatrics Clinic, SS Annunziata Hospital of Chieti, 66100 Chieti, Italy.
Insights
Cardiac sarcoidosis (CS) is a serious manifestation of systemic sarcoidosis. Advanced imaging like CMR and 18F-FDG PET offers a cost-effective diagnostic approach, potentially replacing invasive biopsies.
Area of Science:
- Cardiology
- Pulmonology
- Immunology
Background:
- Cardiac sarcoidosis (CS) is an uncommon yet severe manifestation of systemic sarcoidosis (SA).
- While lungs are typically affected, CS can impact up to 25% of SA patients, often leading to poor prognosis and mortality, especially in African American individuals.
- Non-specific symptoms of CS can mimic other cardiac disorders, complicating diagnosis.
Purpose of the Study:
- To summarize the clinical features and diagnostic imaging findings of cardiac sarcoidosis.
- To highlight the role of cardiovascular magnetic resonance (CMR) and 18-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET) in diagnosing CS.
- To evaluate the cost-benefit ratio of imaging modalities for CS diagnosis.
Main Methods:
- This narrative review synthesizes current literature on cardiac sarcoidosis.
- Focuses on clinical presentations and diagnostic imaging techniques, specifically CMR and 18F-FDG PET.
- Compares the diagnostic utility and risks of imaging versus endomyocardial biopsy.
Main Results:
- Cardiac involvement in sarcoidosis is associated with significant morbidity and mortality.
- CMR and 18F-FDG PET provide valuable insights into CS diagnosis with a favorable cost-benefit ratio.
- Imaging techniques can accurately detect cardiac involvement, guiding treatment decisions.
Conclusions:
- Cardiac sarcoidosis diagnosis is challenging due to non-specific symptoms.
- CMR and 18F-FDG PET are crucial non-invasive tools for diagnosing CS.
- Advanced imaging can reduce the need for invasive procedures like endomyocardial biopsy, improving patient safety.
Abstract:
Cardiac sarcoidosis (CS) is an unusual, but potentially harmful, manifestation of systemic sarcoidosis (SA), a chronic disease characterized by organ involvement from noncaseating and nonnecrotizing granulomas. Lungs and intrathoracic lymph nodes are usually the sites that are most frequently affected, but no organ is spared and CS can affect a variable portion of SA patients, up to 25% from post-mortem studies. The cardiovascular involvement is usually associated with a bad prognosis and is responsible for the major cause of death and complications, particularly in African American patients. Furthermore, the diagnosis is often complicated by the occurrence of non-specific clinical manifestations, which can mimic the effect of more common heart disorders, and imaging and biopsies are the most valid approach to avoid misdiagnosis. This narrative review summarizes the main clinical features of CS and imaging findings, particularly of CMR and 18-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET) that can give the best cost/benefit ratio in terms of the diagnostic approach. Imaging can be very useful in replacing the endomyocardial biopsy in selected cases, to avoid unnecessary, and potentially dangerous, invasive maneuvers.
More Related Videos
09:20Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests